Mindfulness-based Neurofeedback to Augment Psychotherapy for Adults With Borderline Personality Disorder

Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18-60
SponsorYale University

About this trial

The purpose of this study is to test the ability of mindfulness-based real time functional magnetic resonance imaging (fMRI) neurofeedback (mbNF) to increase the benefits of evidence-based psychotherapy for adults with Borderline Personality Disorder (BPD).

Eligibility criteria

Qualifiers

age 18-60,

be able to provide written informed consent,

meet criteria for BPD on semi-structured clinical interview,

able to plan to keep any prescribed medications and psychotherapy constant during the study

Disqualifiers

current DBT psychotherapy outside the study

lifetime primary psychotic disorder

manic episode in the last one year

developmental disorder (e.g. autism)

Trial design

Treatments tested in this trial

  • mindfulness-based Neurofeedback
  • control Neurofeedback

Treatment groups

150 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Yale University

Lead sponsor

Connecticut Mental Health Center

Collaborator

National Institute of Mental Health (NIMH)

Collaborator